Terms: = Head and neck cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Diagnosis
98 results:
1. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract] [Full Text] [Related]
2. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.
Porschen R; Fischbach W; Gockel I; Hollerbach S; Hölscher A; Jansen PL; Miehlke S; Pech O; Stahl M; Vanhoefer U; Ebert MPA
United European Gastroenterol J; 2024 Apr; 12(3):399-411. PubMed ID: 38284661
[TBL] [Abstract] [Full Text] [Related]
3. A mesoporous gold biosensor to investigate immune checkpoint protein heterogeneity in single lung cancer cells.
Ahmed E; Masud MK; Komatineni P; Dey S; Lobb R; Hossain MSA; Möller A; Yamauchi Y; Sina AA; Trau M
Biosens Bioelectron; 2024 Apr; 249():115984. PubMed ID: 38219464
[TBL] [Abstract] [Full Text] [Related]
4. The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers.
Mestiri S; El-Ella DMA; Fernandes Q; Bedhiafi T; Almoghrabi S; Akbar S; Inchakalody V; Assami L; Anwar S; Uddin S; Gul ARZ; Al-Muftah M; Merhi M; Raza A; Dermime S
Biomed Pharmacother; 2024 Feb; 171():116095. PubMed ID: 38183744
[TBL] [Abstract] [Full Text] [Related]
5. Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.
Gao Y; Pan Y; Luo Y; Cheng R; Zhai Q
Ann Diagn Pathol; 2023 Dec; 67():152221. PubMed ID: 37925863
[TBL] [Abstract] [Full Text] [Related]
6. Current and Emerging Role of Monoclonal Antibody-Based First-Line Treatment in Advanced Gastro-Esophageal and Gastric cancer.
Désilets A; Elkhoury R; Gebai A; Tehfe M
Curr Oncol; 2023 Oct; 30(10):9304-9316. PubMed ID: 37887572
[TBL] [Abstract] [Full Text] [Related]
7. Modern diagnostics and treatment of Merkel cell carcinoma.
Weilandt J; Peitsch WK
J Dtsch Dermatol Ges; 2023 Dec; 21(12):1524-1546. PubMed ID: 37875785
[TBL] [Abstract] [Full Text] [Related]
8. What Therapeutic Biomarkers in Gastro-Esophageal Junction and Gastric cancer Should a Pathologist Know About?
Kumarasinghe MP; Houghton D; Allanson BM; Price TJ
Surg Pathol Clin; 2023 Dec; 16(4):659-672. PubMed ID: 37863558
[TBL] [Abstract] [Full Text] [Related]
9. Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNIcancer, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).
Veziant J; Bouché O; Aparicio T; Barret M; El Hajbi F; Lepilliez V; Lesueur P; Maingon P; Pannier D; Quero L; Raoul JL; Renaud F; Seitz JF; Serre AA; Vaillant E; Vermersch M; Voron T; Tougeron D; Piessen G; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2023 Dec; 55(12):1583-1601. PubMed ID: 37635055
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
[TBL] [Abstract] [Full Text] [Related]
11. Acute kidney injury in patients with cancer receiving anti-PD-1/pd-l1 antibodies: incidence, risk factors, and prognosis.
Lou Q; Gong J; Ye B; Yu R; Bu S; Li Y; Zhu B; Shao L
Ren Fail; 2023 Dec; 45(1):2238823. PubMed ID: 37491871
[TBL] [Abstract] [Full Text] [Related]
12. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
[TBL] [Abstract] [Full Text] [Related]
13. Neoadjuvant PD-1/pd-l1 axis blockade for patients with head and neck squamous cell carcinoma.
Huang S; Xiong C; Tan K
Am J Otolaryngol; 2023; 44(6):103985. PubMed ID: 37442083
[TBL] [Abstract] [Full Text] [Related]
14. Exosomal PIK3CB promotes pd-l1 expression and malignant transformation in esophageal squamous cell carcinoma.
Xu W; Chen Y; Zhang Z; Jiang Y; Wang Z
Med Oncol; 2023 Jul; 40(8):221. PubMed ID: 37402056
[TBL] [Abstract] [Full Text] [Related]
15. Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment.
Kaplan HG; Subramaniam S; Vallières E; Barnett T
Oncologist; 2023 Sep; 28(9):765-770. PubMed ID: 37311046
[TBL] [Abstract] [Full Text] [Related]
16. Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review.
Chen Z; Jiang J; Fan Y; Lu H
Diagn Pathol; 2023 May; 18(1):65. PubMed ID: 37198615
[TBL] [Abstract] [Full Text] [Related]
17. Analyses of single extracellular vesicles from non-small lung cancer cells to reveal effects of epidermal growth factor receptor inhibitor treatments.
Stridfeldt F; Cavallaro S; Hååg P; Lewensohn R; Linnros J; Viktorsson K; Dev A
Talanta; 2023 Jul; 259():124553. PubMed ID: 37084607
[TBL] [Abstract] [Full Text] [Related]
18. pd-l1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma.
Zantut-Wittmann DE; Barreto IS; Laus AC; Moreno DA; Moma CA; Maia FFR; Assumpção LVMD; Reis RM
Mol Cell Endocrinol; 2023 Jun; 570():111931. PubMed ID: 37072108
[TBL] [Abstract] [Full Text] [Related]
19. An epulis-like camrelizumab related reactive cutaneous capillary endothelial proliferation (RCCEP) in the oral cavity: A case report.
Hua Y; Huang X; Li C; Gao N
Oral Oncol; 2023 May; 140():106369. PubMed ID: 36989963
[TBL] [Abstract] [Full Text] [Related]
20. The molecular landscape of breast mucoepidermoid carcinoma.
Venetis K; Sajjadi E; Ivanova M; Andaloro S; Pessina S; Zanetti C; Ranghiero A; Citelli G; Rossi C; Lucioni M; Malapelle U; Pagni F; Barberis M; Guerini-Rocco E; Viale G; Fusco N
Cancer Med; 2023 May; 12(9):10725-10737. PubMed ID: 36916425
[TBL] [Abstract] [Full Text] [Related]
[Next]
